Mesenchymal stromal cells promote tumor growth through the enhancement of neovascularization

Molecular Medicine

Volumn 17, Issue 7-8, 2011, Pages 579-587

  Suzuki, Kazuhiro ^a,b   Sun, Ruowen ^a,c   Origuch, Makoto ^d   Kanehira, Masahiko ^d   Takahata, Takenori ^a   Itoh, Jugoh ^a   Umezawa, Akihiro ^e   Kijima, Hiroshi ^b   Fukuda, Shinsaku ^b   Saijo, Yasuo ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

^c CHINA MEDICAL UNIVERSITY   (China)

^d TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKEMIA INHIBITORY FACTOR; MACROPHAGE INFLAMMATORY PROTEIN 2; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MESENCHYME CELL; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; STROMA CELL; TUMOR GROWTH; TUMOR PROMOTION; TUMOR VASCULARIZATION; TUMOR VOLUME;

ANIMALS; ANTIGENS, CD34; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINE CXCL2; COCULTURE TECHNIQUES; FEMALE; FLOW CYTOMETRY; GREEN FLUORESCENT PROTEINS; MACROPHAGE COLONY-STIMULATING FACTOR; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MESENCHYMAL STROMAL CELLS; MICE; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; TUMOR BURDEN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79960720038     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2010.00157     Document Type: Article

References (38)

1. Dvorak HF. (1986). Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315:1650-9.
2. Bissell MJ, Radisky D. (2001). Putting tumours in context. Nat. Rev. Cancer. 1:46-54.
3. Karnoub AE, et al. (2007). Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature. 449:557-63.
4. Hwang RF, et al. (2008). Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res. 68:918-26.
5. Studebaker AW, et al. (2008). Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent manner. Cancer Res. 68:9087-95.
6. Kim S, et al. (2009). Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature. 457:102-6.
7. Grugan KD, et al. (2010). Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion. Proc. Natl. Acad. Sci. U. S. A. 107:11026-31.
8. Paulsson J, et al. (2009). Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer. Am. J. Pathol. 175:334-41.
9. Utispan K, et al. (2010). Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker. Mol. Cancer. 9:13.
10. Wels J, Kaplan RN, Rafii S, Lyden D. (2008). Migratory neighbors and distant invaders: tumorassociated niche cells. Genes. Dev. 22:559-74.
11. Direkze NC, et al. (2004). Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res. 64:8492-5.
12. Udagawa T, Puder M, Wood M, Schaefer BC, D'Amato RJ. (2006). Analysis of tumor-associated stromal cells using SCID GFP transgenic mice: contribution of local and bone marrow-derived host cells. FASEB J. 20:95-102.
13. Worthley DL, et al. (2009). Human gastrointestinal neoplasia-associated myofibroblasts can develop from bone marrow-derived cells following allogeneic stem cell transplantation. Stem Cells. 27:1463-8.
14. Pittenger MF, et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science. 284:143-7.
15. Prockop DJ. (1997). Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 276:71-4.
16. Campagnoli C, et al. (2001). Identification of mesenchymal stem/progenitor cells in human firsttrimester fetal blood, liver, and bone marrow. Blood. 98:2396-402.
17. Karp JM, Leng Teo GS. (2009). Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell. 4:206-16.
18. Ortiz LA, et al. (2003). Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc. Natl. Acad. Sci. U. S. A. 100:8407-11.
19. Lian Q, et al. (2010). Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Circulation. 121:1113-23.
20. Studeny M, et al. (2004). Mesenchymal stem cells: potential precursors for tumor stroma and targeted- delivery vehicles for anticancer agent. J. Natl. Cancer Inst. 96:1593-603.
21. Kidd S, et al. (2009). Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging. Stem Cells. 27:2614-23.
22. Klopp AH, et al. (2007). Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment. Cancer Res. 67:11687-95.
23. Coffelt SB, et al. (2009). The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells. Proc. Natl. Acad. Sci. U. S. A. 106:3806-11.
24. Spaeth EL, et al. (2009). Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS One. 4:e4992.
25. Bexell D, et al. (2009). Bone marrow multipotent mesenchymal stoma cells act as pericyte-like migratory vehicles in experimental gliomas. Mol. Ther. 17:183-90.
26. Khakoo AY, et al. (2006). Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J. Exp. Med. 203:1235-47.
27. Watanabe Y, et al. (1992) A murine thymic stromal cell line which may support the differentiation of CD4-8- thymocytes into CD4+8- alpha beta T cell receptor positive T cells. Cell. Immunol. 142:385-97.
28. Umezawa A, et al. (1992). Multipotent marrow stromal cell line is able to induce hematopoiesis in vivo. J. Cell Physiol. 151:197-205.
29. Annabi B, et al. (2003). Hypoxia promotes murine bone-marrow-derived stromal cell migration and tube formation. Stem Cells. 21:337-47.
30. Sasser AK, et al. (2007). Human bone marrow stromal cells enhance breast cancer cell growth rates in a cell line-dependent manner when evaluated in 3D tumor environments. Cancer Lett. 254:255-64.
31. Ramasamy R, et al. (2007). Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth. Leukemia. 21:304-10.
32. Djouad F, et al. (2003). Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood. 102:3837-44.
33. Beckermann BM, et al. (2008). VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma. Br. J. Cancer. 99:622-31.
34. Otsu K, et al. (2009). Concentration-dependent inhibition of angiogenesis by mesenchymal stem cells. Blood. 113:4197-205.
35. Gunn WG, et al. (2006). A crosstalk between myeloma cells and marrow stromal cells stimulates production of DKK1 and interleukin-6: a potential role in the development of lytic bone disease and tumor progression in multiple myeloma. Stem Cells. 24:986-91.
36. Romieu-Mourez R, et al. (2009). Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype. J. Immunol. 182:7963-73.
37. Potier E, et al. (2007). Hypoxia affects mesenchymal stromal cell osteogenic differentiation and angiogenic factor expression. Bone. 40:1078-87.
38. Mishra PJ, et al. (2008). Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res. 68:4331-9.